Develops drugs for various diseases, including cancer and infections.
Jun 2026Revenue $39.9M/yrExpenses $49.5M/yr
No trend
Figures by year
When will Cumberland Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $39.9M and expenses $49.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $44.5M | $47.3M | −$2.79M |
| Dec 2024 | $37.9M | $44.3M | −$6.43M |
| Dec 2023 | $39.6M | $49.1M | −$9.55M |
| Dec 2022 | $42.0M | $47.7M | −$5.70M |
| Dec 2021 | $35.0M | $42.7M | −$7.68M |
| Dec 2020 | $35.8M | $42.2M | −$6.38M |
| Dec 2019 | $32.4M | $41.7M | −$9.29M |
| Dec 2018 | $28.8M | $40.0M | −$11.2M |
| Dec 2017 | $40.4M | $44.5M | −$4.08M |
| Dec 2016 | $32.5M | $33.9M | −$1.43M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.